Report #2842073

Received May 21, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: TN
Recovered: Unknown
Vaccinated: May 3, 2025
Onset: May 3, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	UNK	X019863	OT

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

No additional AE; HCP calling to report expired administration of GARDASIL-9 on 05/03/2025. The product was expired on 02/14/2025 with no TEs. No symptoms reported on behalf of patient. Supported outcome delivered verbally per memo. Case number provided. Received cons; This spontaneous report was received from a Pharmacist and refers to a female patient of unknown age. Her medical history, concurrent conditions and concomitant therapies were not provided. On 03-MAY-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) suspension for injection, lot #X019863, expiration date: 14-FEB-2025, administered by unknown route for prophylaxis (dose and strength were not provided) (Expired product administered). No additional AE. At the reporting time, the outcome of the events was unknown. The action taken with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) was not reported but established to be as not applicable.